Table 3.

Adjusted ORs and 95% CIs for the presence of major renal function decline according to baseline dyslipidaemia and abnormal AIP.

	Unadjusted		Model 1		Model 2
	OR (95% CI)	p Value	OR (95% CI)	p Value	OR (95% CI)	p Value
Total
Elevated TG	2.17 (1.17–4.04)	0.014	2.26 (1.18–4.34)	0.014	1.74 (0.86–3.53)	0.123
Elevated TC	2.23 (0.95–5.23)	0.067	2.26 (0.95–5.39)	0.066	1.98 (0.81–4.83)	0.132
Reduced HDL-C	1.61 (0.91–2.85)	0.105	1.65 (0.90–3.04)	0.107	1.55 (0.82–2.94)	0.177
Elevated LDL-C	1.04 (0.32–3.34)	0.953	1.03 (0.32–3.34)	0.963	0.95 (0.29–3.14)	0.933
Abnormal AIP	2.17 (1.30–3.62)	0.003	2.43 (1.38–4.29)	0.002	2.18 (1.18–4.05)	0.013
Men
Elevated TG	2.04 (0.97–4.28)	0.061	2.16 (1.02–4.59)	0.045	1.78 (0.77–4.11)	0.173
Elevated TC	2.70 (0.93–7.81)	0.067	2.81 (0.97–8.18)	0.058	2.49 (0.82–7.61)	0.109
Reduced HDL-C	1.35 (0.67–2.74)	0.400	1.35 (0.67–2.74)	0.400	1.34 (0.63–2.87)	0.451
Elevated LDL-C	1.05 (0.25–4.42)	0.951	1.07 (0.25–4.52)	0.927	1.07 (0.25–4.69)	0.925
Abnormal AIP	2.09 (1.07–4.11)	0.030	2.15 (1.10–4.22)	0.026	2.16 (1.02–4.55)	0.044
Women
Elevated TG	2.93 (0.86–9.94)	0.085	2.70 (0.77–9.52)	0.121	2.02 (0.52–7.88)	0.310
Elevated TC	1.64 (0.38–7.05)	0.505	1.44 (0.32–6.49)	0.635	1.31 (0.29–6.00)	0.726
Reduced HDL-C	2.97 (1.00–8.75)	0.048	2.87 (0.97–8.49)	0.057	2.57 (0.83–7.96)	0.101
Elevated LDL-C	0.99 (0.13–7.46)	0.998	0.86 (0.11–6.62)	0.881	0.75 (0.10–5.92)	0.787
Abnormal AIP	3.09 (1.23–7.75)	0.016	2.98 (1.13–7.85)	0.028	2.41 (0.82–7.04)	0.107

Model 1: adjusted for baseline age and gender.

Model 2: adjusted for covariates in model 1 plus baseline BMI, FPG, uric acid, eGFR, SBP and DBP.

CIs: confidence intervals; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; AIP: atherogenic index of plasma; BMI: body mass index; FBG: fasting blood glucose; eGFR: estimated glomerular filtration rate.